Fleury (FLRY3.SA) Stock Price

Fleury Price

B3·CLOSED
16.41BRL+0.11 (+0.67 %)
Market closed

Over the last 19 years Fleury grew revenue by 16.1% annually, reaching 8.29 B BRL. Earnings per share have declined at 9.8% per year over the last 19 years. For Fleury, the net margin of 7.4% is down versus 9.0% a few years ago. At today's price the dividend yield works out to roughly 10.21%. The payout ratio is around 149% of earnings. The dividend has grown at 12.0% per year over the past 15 years. The consensus 12-month price target for Fleury is 18.36 BRL, about 11.9% above where the stock trades today. Of 19 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 30% above its 52-week low.

Fleury stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Fleury over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Fleury stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Fleury's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Fleury Stock Price History
DateFleury Price
7/14/202616.41 BRL
7/13/202616.30 BRL
7/10/202616.42 BRL
7/9/202615.75 BRL
7/8/202615.44 BRL
7/7/202615.57 BRL
7/6/202615.65 BRL
7/3/202615.81 BRL
7/2/202615.78 BRL
7/1/202615.48 BRL
6/30/202615.40 BRL
6/29/202615.55 BRL
6/26/202615.61 BRL
6/25/202615.45 BRL
6/24/202615.16 BRL
6/23/202615.07 BRL
6/22/202614.97 BRL
6/19/202614.90 BRL
6/18/202614.93 BRL
6/17/202614.90 BRL
6/16/202614.79 BRL
6/15/202615.05 BRL
6/12/202615.26 BRL
6/11/202614.72 BRL
6/10/202614.86 BRL
6/9/202615.21 BRL
6/8/202614.61 BRL
6/5/202614.73 BRL
6/3/202614.87 BRL
6/2/202615.37 BRL
6/1/202615.23 BRL
5/29/202615.43 BRL
5/28/202615.75 BRL
5/27/202616.15 BRL
5/26/202615.86 BRL
5/25/202615.81 BRL
5/22/202615.54 BRL
5/21/202615.49 BRL
5/20/202615.86 BRL
5/19/202615.32 BRL
5/18/202615.62 BRL
5/15/202615.60 BRL
5/14/202615.96 BRL
5/13/202615.90 BRL
5/12/202616.25 BRL
5/11/202616.34 BRL
5/8/202616.58 BRL
5/7/202616.25 BRL
5/6/202616.83 BRL
5/5/202616.38 BRL
5/4/202616.29 BRL
4/30/202616.08 BRL
4/29/202616.03 BRL
4/28/202615.92 BRL
4/27/202615.99 BRL
4/24/202616.21 BRL
4/23/202616.32 BRL
4/22/202616.50 BRL
4/20/202616.68 BRL
4/17/202616.65 BRL
4/16/202617.09 BRL
4/15/202617.05 BRL
4/14/202617.68 BRL
4/13/202617.26 BRL
4/10/202616.92 BRL
4/9/202616.78 BRL
4/8/202616.13 BRL
4/7/202615.91 BRL
4/6/202615.92 BRL
4/2/202615.88 BRL
4/1/202616.03 BRL
3/31/202615.93 BRL
3/30/202615.68 BRL
3/27/202615.35 BRL
3/26/202615.45 BRL
3/25/202615.73 BRL
3/24/202615.40 BRL
3/23/202615.56 BRL
3/20/202614.91 BRL
3/19/202615.34 BRL
3/18/202615.34 BRL
3/17/202615.49 BRL
3/16/202615.55 BRL
3/13/202615.39 BRL
3/12/202615.66 BRL
3/11/202616.25 BRL
3/10/202616.27 BRL
3/9/202615.92 BRL
3/6/202616.02 BRL
3/5/202616.03 BRL
3/4/202616.58 BRL
3/3/202616.42 BRL
3/2/202616.90 BRL
2/27/202616.82 BRL
2/26/202617.24 BRL
2/25/202617.57 BRL
2/24/202617.60 BRL
2/23/202617.55 BRL
2/20/202617.87 BRL
2/19/202617.95 BRL
2/18/202617.75 BRL
2/13/202617.46 BRL
2/12/202617.34 BRL
2/11/202617.15 BRL
2/10/202616.90 BRL
2/9/202616.94 BRL
2/6/202616.93 BRL
2/5/202616.84 BRL
2/4/202616.48 BRL
2/3/202616.95 BRL
2/2/202616.87 BRL
1/30/202616.62 BRL
1/29/202616.80 BRL
1/28/202617.10 BRL
1/27/202617.01 BRL
1/26/202616.78 BRL
1/23/202616.77 BRL
1/22/202616.47 BRL
1/21/202616.02 BRL
1/20/202615.64 BRL
1/19/202615.60 BRL
12/17/202514.63 BRL
12/16/202514.77 BRL
12/15/202515.20 BRL
12/12/202515.08 BRL
12/11/202514.81 BRL
12/10/202514.82 BRL
12/9/202514.41 BRL
12/8/202514.50 BRL
12/5/202514.49 BRL
12/4/202515.39 BRL
12/3/202515.20 BRL
12/2/202516.10 BRL
12/1/202515.91 BRL
11/28/202516.05 BRL
11/27/202515.64 BRL
11/26/202515.52 BRL
11/25/202515.03 BRL
11/24/202515.23 BRL
11/21/202515.33 BRL
11/19/202515.63 BRL
11/18/202515.64 BRL
11/17/202515.78 BRL
11/14/202515.90 BRL
11/13/202515.85 BRL
11/12/202516.14 BRL
11/11/202515.82 BRL
11/10/202515.77 BRL
11/7/202515.70 BRL
11/6/202515.10 BRL
11/5/202514.81 BRL
11/4/202514.55 BRL
11/3/202514.53 BRL
10/31/202514.55 BRL
10/30/202514.47 BRL
10/29/202514.49 BRL
10/28/202514.66 BRL
10/27/202514.64 BRL
10/24/202514.45 BRL
10/23/202514.20 BRL
10/22/202514.45 BRL
10/21/202514.85 BRL
10/20/202514.91 BRL
10/17/202515.58 BRL
10/16/202515.36 BRL
10/15/202515.48 BRL
10/14/202515.35 BRL
10/13/202515.45 BRL
10/10/202515.43 BRL
10/9/202515.48 BRL
10/8/202515.61 BRL
10/7/202515.75 BRL
10/6/202515.92 BRL
10/3/202516.00 BRL
10/2/202516.00 BRL
10/1/202515.96 BRL
9/30/202516.14 BRL
9/29/202516.14 BRL
9/26/202516.09 BRL
9/25/202516.05 BRL
9/24/202516.26 BRL
9/23/202516.08 BRL
9/22/202515.94 BRL
9/19/202515.97 BRL
9/18/202515.53 BRL
9/17/202515.58 BRL
9/16/202515.61 BRL
9/15/202515.57 BRL
9/12/202515.80 BRL
9/11/202515.60 BRL
9/10/202515.72 BRL
9/9/202515.79 BRL
9/8/202515.71 BRL
9/5/202515.77 BRL
9/4/202515.43 BRL
9/3/202515.40 BRL
9/2/202515.23 BRL
9/1/202515.37 BRL
8/29/202514.89 BRL
8/28/202514.60 BRL
8/27/202514.34 BRL
8/26/202514.15 BRL
8/25/202514.19 BRL
8/22/202514.21 BRL
8/21/202513.90 BRL
8/20/202513.95 BRL
8/19/202513.96 BRL
8/18/202514.17 BRL
8/15/202514.08 BRL
8/14/202513.94 BRL
8/13/202513.97 BRL
8/12/202514.38 BRL
8/11/202514.28 BRL
8/8/202514.35 BRL
8/7/202514.55 BRL
8/6/202514.58 BRL
8/5/202514.24 BRL
8/4/202514.30 BRL
8/1/202514.24 BRL
7/31/202514.35 BRL
7/30/202514.54 BRL
7/29/202514.43 BRL
7/28/202514.42 BRL
7/25/202514.48 BRL
7/24/202514.15 BRL
7/23/202514.51 BRL
7/22/202514.39 BRL
7/21/202514.51 BRL
7/18/202512.63 BRL
7/17/202512.78 BRL
7/16/202512.82 BRL
Access this data via the Eulerpool API
Get Free API Key

Fleury Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
6.47 B BRL
911.20 M BRL
423.76 M BRL
Jan 1, 2024
7.68 B BRL
1.21 B BRL
616.17 M BRL
Jan 1, 2025
8.29 B BRL
1.23 B BRL
612.83 M BRL
Jan 1, 2026 (e)
9.25 B BRL
1.41 B BRL
719.40 M BRL
Jan 1, 2027 (e)
9.87 B BRL
1.54 B BRL
840.40 M BRL
Jan 1, 2028 (e)
10.02 B BRL
1.63 B BRL
775.43 M BRL
Jan 1, 2029 (e)
11.20 B BRL
1.66 B BRL
893.19 M BRL
Jan 1, 2030 (e)
11.79 B BRL
1.77 B BRL
936.47 M BRL

Fleury Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 15, 2026, 4:07 PM
 
REVENUEB BRL
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB BRL
NET INCOMEM BRL
NET INCOME GROWTH%
DIV.BRL
DIV. GROWTH%
SHARESM
20162017201820192020202120222023202420252026e2027e2028e2029e2030e2031e
2.102.382.662.912.973.874.466.477.688.299.259.8710.0211.2011.7912.42
10.6713.6911.799.052.2730.3315.2644.9718.767.9011.576.701.5211.775.315.27
28.6730.8930.3330.5727.2329.0827.1126.8827.8926.6126.6126.6126.6126.6126.6126.61
0.600.740.810.890.811.131.211.742.142.212.462.632.672.983.143.30
228.00320.00331.00312.00256.00349.00307.00423.00616.00612.00719.00840.00775.00893.00936.00990.00
113.0840.353.44-5.74-17.9536.33-12.0337.7945.63-0.6517.4816.83-7.7415.234.825.77
––––––––––––––––
––––––––––––––––
321.89327.77325.71323.37339.15336.97338.93484.47545.17544.95544.95544.95544.95544.95544.95544.95
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Fleury generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Fleury retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Fleury's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Fleury has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Fleury's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Fleury stock margins

The Fleury margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fleury. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fleury.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
29.10 %
17.13 %
9.04 %
Jan 1, 2022
27.11 %
16.42 %
6.90 %
Jan 1, 2023
26.89 %
14.08 %
6.55 %
Jan 1, 2024
27.89 %
15.72 %
8.02 %
Jan 1, 2025
26.61 %
14.85 %
7.39 %
Jan 1, 2026 (e)
26.61 %
15.23 %
7.78 %
Jan 1, 2027 (e)
26.61 %
15.58 %
8.51 %
Jan 1, 2028 (e)
26.61 %
16.26 %
7.74 %

Fleury Stock Revenue, EBIT, Earnings per Share

The Fleury earnings per share therefore indicates how much revenue Fleury has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
11.49 BRL
1.97 BRL
1.04 BRL
Jan 1, 2022
13.17 BRL
2.16 BRL
0.91 BRL
Jan 1, 2023
13.36 BRL
1.88 BRL
0.87 BRL
Jan 1, 2024
14.10 BRL
2.22 BRL
1.13 BRL
Jan 1, 2025
15.21 BRL
2.26 BRL
1.12 BRL
Jan 1, 2026 (e)
16.97 BRL
2.59 BRL
1.32 BRL
Jan 1, 2027 (e)
18.11 BRL
2.82 BRL
1.54 BRL
Jan 1, 2028 (e)
18.39 BRL
2.99 BRL
1.42 BRL

Fleury business model & stock analysis

The history of Fleury SA begins in 1926 when the Fleury family opened a small butcher shop in Lyon, France. The family quickly gained a reputation for their high-quality meats and sausages and started supplying restaurants and hotels. Over the following decades, Fleury SA developed into a leading company in the food industry. The management recognized the importance of innovation and diversification early on, and the company became a major provider of frozen and fresh products, including meat, fish, and vegetables. Today, Fleury SA is an internationally operating company based in Lyon with branches in several countries. The company's core business includes the production and marketing of food in four different areas: 1) Fresh products: Fleury SA is known for its high-quality meats and sausages, including beef, pork, poultry, and game. The company also offers a wide range of fish products, including salmon, trout, and tuna. 2) Frozen products: Fleury SA is a significant supplier of frozen products, including meat, fish, vegetables, and ready meals. The company places great importance on the high quality and sustainability of its products. 3) Food ingredients: Fleury SA also produces a range of food ingredients that are widely used in the food industry. These include spices, herbs, and flavors. 4) Private labels: Another important division of Fleury SA is the production of private labels. The company works with retailers to manufacture their products under their own brand. Fleury SA's products are sold through a variety of distribution channels, including supermarkets, restaurants, and hotels. The company also heavily relies on its online presence and offers a wide range of products through its online shop. Over the years, the company has received numerous awards for its products and innovations. Fleury SA is proud of its efforts to promote sustainable and ethical business practices and is committed to environmental protection and animal welfare in the food industry. Overall, Fleury SA is a successful and innovative company that stays true to its roots and values. Through its focus on quality, sustainability, and diversification, the company has secured a solid position in the food industry.

Fleury SWOT Analysis

Strengths

Fleury SA has established itself as a leading healthcare provider in Brazil, boasting a strong brand reputation and a wide range of medical services.

The company has a vast network of hospitals, labs, and clinics, allowing it to serve a large customer base and generate significant revenue.

Fleury SA's technological capabilities and investment in advanced medical equipment enable them to offer high-quality and accurate diagnostic services.

Weaknesses

One weakness of Fleury SA is its heavy dependency on the Brazilian healthcare system. Any changes in government policies or regulations can significantly impact the company's operations and profitability.

The high cost of healthcare services provided by Fleury SA may limit access for some potential customers.

Fleury SA's expansion plans outside of Brazil are limited, potentially hindering its growth opportunities in international markets.

Opportunities

With the increasing demand for healthcare services in Brazil, Fleury SA has the opportunity to expand its market share and reach a larger customer base.

There is a growing trend towards preventive healthcare, which opens up opportunities for Fleury SA to develop and offer new services focused on early detection and disease prevention.

International expansion into emerging markets could diversify Fleury SA's revenue streams and reduce its reliance on the Brazilian market.

Threats

Intense competition within the Brazilian healthcare industry poses a threat to Fleury SA's market position and profitability.

Economic downturns and fluctuations in healthcare spending can negatively impact Fleury SA's revenue and financial performance.

Changes in healthcare regulations and reimbursement policies can create challenges for Fleury SA in terms of cost control and compliance.

Fleury Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Fleury historical P/E ratio, EBIT multiple, and P/S ratio

Fleury annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Fleury shares outstanding

The number of shares of Fleury was 544.95 M in 2025. This indicates how many shares Fleury is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
336.97 M Stocks
Jan 1, 2022
338.93 M Stocks
Jan 1, 2023
484.47 M Stocks
Jan 1, 2024
545.17 M Stocks
Jan 1, 2025
544.95 M Stocks
Jan 1, 2026 (e)
544.95 M Stocks
Jan 1, 2027 (e)
544.95 M Stocks
Jan 1, 2028 (e)
544.95 M Stocks

Fleury stock splits

In Fleury's history, there have been no stock splits.

Fleury Dividend History

16 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20251.68BRL↑ 139.7%3×
Mar 7, 20250.47BRL↑ 117.9%1/3
Aug 13, 20250.31BRL↓ 33.5%2/3
Dec 3, 20250.90BRL↑ 189.9%3/3
20240.70BRL↑ 60.7%3×
20230.43BRL↓ 56.7%2×
20221.00BRL↑ 4.9%2×
20210.96BRL↑ 30.0%4×
20200.74BRL↓ 27.4%2×
20191.01BRL↑ 5.5%3×
20180.96BRL↑ 50.3%3×
20170.64BRL↓ 38.6%2×
20161.04BRL↑ 905.5%3×

Fleury dividend history and estimates

In 2025, Fleury paid a dividend amounting to 1.68 BRL. Dividend means that Fleury distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021 (e)
0.96 BRL
0.00 BRL
0.51 BRL
Jan 1, 2022 (e)
1.00 BRL
0.00 BRL
0.90 BRL
Jan 1, 2023 (e)
0.43 BRL
0.00 BRL
0.94 BRL
Jan 1, 2024 (e)
0.70 BRL
0.00 BRL
0.81 BRL
Jan 1, 2025 (e)
1.68 BRL
0.00 BRL
0.68 BRL
Jan 1, 2026 (e)
0.00 BRL
0.00 BRL
0.95 BRL
Jan 1, 2027 (e)
0.00 BRL
0.00 BRL
0.43 BRL
Jan 1, 2028 (e)
0.00 BRL
0.00 BRL
0.70 BRL

Fleury dividend payout ratio

In 2025, Fleury had a payout ratio of 148.97%. The payout ratio indicates the percentage of the company's profits that Fleury distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
86.97 %
Jan 1, 2022
104.55 %
Jan 1, 2023
49.71 %
Jan 1, 2024
61.84 %
Jan 1, 2025
148.97 %
Jan 1, 2026 (e)
0.00 %
Jan 1, 2027 (e)
0.00 %
Jan 1, 2028 (e)
0.00 %

Current Fleury forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.55 %
Buy57.89 % (11)
Hold31.58 % (6)
Sell10.53 % (2)
12M Price Target
18.36
Last Price
16.41
Currency
BRL
12M Return Potential
11.88 %
LTM Return
0 %

Fleury Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
5/2/20240.34BRL2.02 BBRL2024 Q1
3/14/20240.22BRL1.85 BBRL2023 Q4

EESG©

Eulerpool ESG Scorecard© for the Fleury stock

87/100
99
Environment
99
Social
62
Governance
E

Environment

20
Scope 1 - Direct Emissions7,918.57
Scope 2 - Indirect emissions from purchased energy3,755.06
Scope 3 - Indirect emissions within the value chain141,173.84
Total CO₂ emissions11,673.63
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees79
Percentage of women in management—
Percentage of Asian employees11
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees52
Black Management Share—
Percentage of white employees35
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Fleury shareholder structure

% Name
41.35614%
ICBC Investments Argentina S.A.
ICBC Investments Argentina S.A.
24.94895%
Bradseg Participações, Ltda.
Bradseg Participações, Ltda.
6.64063%
Pardini (Regina)
Pardini (Regina)
6.63206%
Pardini (Victor Cavalcanti)
Pardini (Victor Cavalcanti)
6.53853%
Pardini (Aurea Maria)
Pardini (Aurea Maria)
4.98094%
Guepardo Investimentos, Ltda.
Guepardo Investimentos, Ltda.
...

Fleury Executives and Management Board

MM

Mr. Marcio Mendes

(51)

Chairman of the Board

JT

Ms. Jeane Tsutsui

(55)

Chief Executive Officer, Member of the Executive Board · since 2021

FA

Mr. Fernando Alberto

(56)

Vice Chairman of the Board

JF

Mr. Jose de Almeida Filippo

(64)

Chief Financial and Investor Relations Officer, Member of the Executive Board

PB

Ms. Patricia Bertoncello

(42)

Member of the Executive Board, Service Units Officer

Frequently asked questions about Fleury

The business model of Fleury SA, a leading medical diagnostics company in Brazil, revolves around providing high-quality healthcare services through its network of diagnostic imaging, clinical analysis, and other medical services. Fleury SA aims to ensure accurate diagnoses, offer timely access to medical procedures, and deliver exceptional customer experience. By investing in advanced technology, top-notch professionals, and continuous innovation, Fleury SA effectively meets the healthcare needs of patients across the country. With its strong reputation and diverse range of diagnostic services, Fleury SA strives to maintain its position as a market leader in Brazil's healthcare industry.

All fundamentals and in-depth analysis of Fleury

Our stock analysis for Fleury stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fleury. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Fleury Stock
Fleury Revenue→
Fleury Stock
Fleury Net Income→
Fleury Stock
Fleury P/E→
Fleury Stock
Fleury P/S→
Fleury Stock
Fleury EBIT→
Fleury Stock
Fleury Dividend→
Fleury Stock
Fleury Directors Dealings→
Fleury Stock
Fleury Stocks→
Fleury Stock
Fleury Market capitalization→
Fleury Stock
Fleury Debt→
Fleury Stock
Fleury Liabilities→
Fleury Stock
Fleury Equity→
Fleury Stock
Fleury AAQS→
Fleury Stock
Fleury Employees→
Fleury Stock
Fleury ROE→
Fleury Stock
Fleury ROA→
Fleury Stock
Fleury ROCE→
Fleury Stock
Fleury News→
Fleury Stock
Fleury Analyst Price Targets→

Health Stocks

Flexion TherapeuticsFlerieFluicellFisher & Paykel Healthcare CorporationFluoguide ASFirst Choice Healthcare SolutionsFluoroPharma MedicalFirebrick PharmaFoghorn TherapeuticsFine Foods & Pharmaceuticals NTM SpAForesee Pharmaceuticals CoFindexAll Stocks A–Z →